What type of study is this?

This is a In Vitro Study study.

What question did this study set out to answer?

To develop a metal-phenolic nanoparticle for targeted and safe tPA delivery in ischemic stroke treatment.

View Full Paper

Ask AI

Bookmark

Authors

Nanoparticle therapy improves thrombolysis outcomes in ischemic stroke, suggesting a novel approach to reduce bleeding risks.

To develop a metal-phenolic nanoparticle for targeted and safe tPA delivery in ischemic stroke treatment.
Created MPN@tPA@GP hybrid nanoparticles using a self-assembly method based on metal-phenolic networks.
Screened eight fibrin-targeting peptides for thrombus binding efficiency in vitro.
Conducted in vivo studies in animal models to assess thrombus targeting and therapeutic efficacy.
Demonstrated efficient pH-sensitive release of tPA from the nanoparticles in vitro.
Showed improved thrombus binding and penetration in two animal models.
Achieved reduced tPA-induced hemorrhage risk compared to conventional methods.

Zhao et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark